Articles related to Cardiology, Interventional

Recent research indicates that myocarditis and pericarditis occur solely in vaccinated children and adolescents, not in those infected with COVID-19. Despite higher risks of heart inflammation, vaccinated adolescents showed reduced rates of COVID-19 infection and severe outcomes.

This study evaluates the use of statins for primary prevention of cardiovascular diseases in adults aged 75 years and older, demonstrating a significant reduction in CVD incidence without an increase in severe adverse events. These findings provide real-world evidence to guide clinical decision-making in this underrepresented population.

Statins, although effective at lowering cholesterol, may inadvertently impair immune function by reducing vitamin D synthesis. This opinion piece examines how this could have influenced COVID-19 outcomes, highlighting critical considerations for clinical practice.

Prehospital management of blood pressure in patients with suspected acute stroke shows varying impacts depending on the stroke type. Immediate reduction improves outcomes in hemorrhagic stroke but may worsen outcomes in ischemic stroke, emphasizing the need for tailored approaches in early stroke care.

The phase 3 trial of aficamten for symptomatic obstructive hypertrophic cardiomyopathy showed a significant improvement in peak oxygen uptake compared to placebo, with meaningful enhancements in patient-reported outcomes and clinical measures.

A case of pacemaker-lead dislodgement with cardiac perforation in a 96-year-old patient highlights the importance of recognizing and addressing complications swiftly to prevent severe outcomes.